Orthocell - Model Ortho-ATI - Autologous Tenocyte Implantation
Orthocell’s OrthoATI™ is a cell therapy for treatment of chronic degenerative tendon injuries. OrthoATI™ addresses a significant unmet clinical need for a non-surgical solution for a debilitating injury affecting millions of people every year. OrthoATI™ addresses the underlying pathology of tendon injury, replenishing degenerative tissue with healthy mature tendon cells. This unique treatment uses each patient’s own tendon-derived cells to stimulate tendon regeneration and is delivered via ultrasound guided injection under local anaesthetic. Orthocell has embarked on an evidenced based clinical development program focused on safety and performance in multiple tendon indications, including shoulder, elbow, hip, knee and ankle.
-
Most popular related searches
How does Ortho-ATI™ work?
A biopsy of healthy tendon, performed in a doctor's rooms using a local anaesthetic, is sent to our GMP-licensed laboratory where tendon cells are cultivated under controlled conditions. The tendon cells are then implanted by injection into the affected tendon approximately 4 – 5 weeks after the initial biopsy. The injection is given in the doctor's rooms as a walk-in/walk-out procedure.
Customer reviews
No reviews were found for Orthocell - Model Ortho-ATI - Autologous Tenocyte Implantation. Be the first to review!